6-158767331-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001111077.2(EZR):c.1526G>A(p.Arg509Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000607 in 1,614,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001111077.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EZR | NM_001111077.2 | c.1526G>A | p.Arg509Gln | missense_variant | 13/14 | ENST00000367075.4 | NP_001104547.1 | |
EZR | NM_003379.5 | c.1526G>A | p.Arg509Gln | missense_variant | 12/13 | NP_003370.2 | ||
EZR | XM_011536110.2 | c.1118G>A | p.Arg373Gln | missense_variant | 9/10 | XP_011534412.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EZR | ENST00000367075.4 | c.1526G>A | p.Arg509Gln | missense_variant | 13/14 | 1 | NM_001111077.2 | ENSP00000356042 | P1 | |
EZR | ENST00000337147.11 | c.1526G>A | p.Arg509Gln | missense_variant | 12/13 | 1 | ENSP00000338934 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000478 AC: 12AN: 251222Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135794
GnomAD4 exome AF: 0.0000629 AC: 92AN: 1461872Hom.: 0 Cov.: 40 AF XY: 0.0000633 AC XY: 46AN XY: 727242
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74330
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 20, 2024 | The c.1526G>A (p.R509Q) alteration is located in exon 12 (coding exon 12) of the EZR gene. This alteration results from a G to A substitution at nucleotide position 1526, causing the arginine (R) at amino acid position 509 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at